Adrenaline (ICU — Vasopressor/Inotrope)
Brand names: Epinephrine
Adrenaline (epinephrine) is the first-line treatment of anaphylaxis (intramuscular), is used in cardiac arrest, and as an intravenous vasopressor/inotrope in shock.
Adult dose
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
US labelling (FDA)
Reference — US labelling, may differ from UK• Hypotension associated with septic shock ( 2.2 ) : o Dilute epinephrine in dextrose solution prior to infusion. o Infuse epinephrine into a large vein. o Titrate 0.05 mcg/kg/min to 2 mcg/kg/min to achieve desired blood pressure. o Wean gradually. 2.1 General Considerations Inspect visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not use if the solution is colored or cloudy, or if it contains particulate matter. Discard any unused portion. 2.2 Hypotension associated with Septic Shock Dilute epinephrine in 5% Dextrose Injection, USP or 5% Dextrose and Sodium Chloride solution. These dextrose containing fluids provide …
Source: US FDA prescribing information (openFDA / DailyMed), label dated 2026-06-08. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.
Contraindications
- US labelling states None. UK SPC (1:1000 ampoule) lists: hypersensitivity to active substance/excipients (relative — emergency use); avoid use in fingers, toes, ears, nose, genitalia or buttocks (ischaemic necrosis); do not use if discoloured
Side effects
- Tachycardia, supraventricular tachycardia, ventricular arrhythmias, myocardial ischaemia, myocardial infarction
- Limb ischaemia, pulmonary oedema, extravasation (with tissue necrosis)
- Headache, nervousness, paraesthesia, tremor, stroke, CNS bleeding
- Hyperglycaemia/hypoglycaemia, insulin resistance, hypokalaemia, lactic acidosis
- Renal insufficiency; nausea, vomiting, chest pain
Interactions
- Drugs antagonising pressor effects: alpha-blockers, vasodilators (nitrates), diuretics, antihypertensives, ergot alkaloids, phenothiazine antipsychotics
- Drugs potentiating pressor effects: sympathomimetics, beta-blockers, tricyclic antidepressants, MAO inhibitors, COMT inhibitors, clonidine, doxapram, oxytocin
- Drugs increasing arrhythmogenic potential: beta-blockers, cyclopropane/halogenated hydrocarbon anaesthetics, quinidine, antihistamines, thyroid hormones, diuretics, cardiac glycosides
- Potassium-depleting drugs (corticosteroids, diuretics, theophylline) potentiate hypokalaemic effects
Clinical monograph
How it works
It stimulates alpha- and beta-adrenoceptors, producing vasoconstriction, increased cardiac rate and force, and bronchodilation.
Prescribing in practice
- For anaphylaxis the intramuscular route (anterolateral thigh) is first-line and repeated as needed; the intramuscular and intravenous concentrations differ and must never be confused.
- Intravenous use is for cardiac arrest or a titrated infusion in critical care with monitoring.
- It can cause tachyarrhythmia, hypertension and tissue ischaemia; infusion extravasation causes local injury.
Monitoring
In anaphylaxis monitor airway, breathing, circulation and response; for infusions monitor ECG, blood pressure and the infusion site.
Counselling the patient
- After using an auto-injector for a severe allergic reaction, always call emergency services — a second reaction can occur.
- Carry two auto-injectors if prescribed and know how and when to use them.
Evidence & guidelines
First-line for anaphylaxis (Resuscitation Council UK) and used in cardiac arrest and shock.
Reference: Surviving Sepsis Campaign Guidelines 2021; Resuscitation Council UK ALS 2021; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.